1/19
Adrenal Steroid and Related Drugs
Fludrocortisone MOA
mineralocorticoid
Fludrocortisone and Hydrocortisone primary indication
replacement therapy in patients with primary adrenal insufficiency (Addison’s)
Hydrocortisone MOA
pharmaceutical preparation of cortisol
some mineralocorticoid activity
Hydrocortisone side effect / notable aspects
considered “low potency”
8-12 hour duration of action
side effects include elements of Cushing syndrome at supraphysiologic doses for more than 2 weeks (buffalo hump, hirsutism, muscle wasting, acne, skin bruising)
Prednisone MOA
glucocorticoid
some mineralocorticoid activity
Prednisone primary indication
treats autoimmune conditions, inflammation
Prednisone side effects/ notable aspects
medium potency
12-36 hours duration of action
Cushing syndrome features
Dexamethasone MOA
glucocorticoid
Dexamethasone primary indication
used in diagnostic dexamethasone test
treats inflammatory conditions
Dexamethasone side effects / notable aspects
high potency
24-72 hours duration of action
Cushing syndrome features
Metyrapone MOA
inhibit synthesis of glucocorticoids by inhibiting 11 beta-hydroxylase
Metyrapone primary indication
treatment of Cushing syndrome in non-surgical candidates
Metyrapone side effects
effects of too many androgens on the body
Ketoconazole MOA
antifungal drug which inhibits cytochrome P450 enzymes involved in steroid synthesis including 11 beta-hydroxylase
lowers amount of cortisol
Ketoconazole primary indication
treatment of Cushing syndrome
Mifepristone MOA
glucocorticoid receptor antagonist AND progesterone receptor antagonist
Mifepristone primary indication
treatment of Cushing syndrome
(also used for medication termination of pregnancy)
Spironolactone MOA
aldosterone antagonist
Spironolactone primary indication
used as potassium sparing diuretic
treats primary hyperaldosteronism caused by bilateral adrenal hyperaldosteronism
Spironolactone side effect
hyperkalemia